📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

What do we mean by identifiability in mixed effects models? (2016)

First Author: Lavielle M

Attributed to: Rare disease use of clinical trial simulation for the chioce and optimization of study designs/Priomedchild Call/ER funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s10928-015-9459-4

PubMed Identifier: 26660913

Publication URI: http://europepmc.org/abstract/MED/26660913

Type: Journal Article/Review

Volume: 43

Parent Publication: Journal of pharmacokinetics and pharmacodynamics

Issue: 1

ISSN: 1567-567X